Medical Properties Trust Yönetim

Yönetim kriter kontrolleri 2/4

Medical Properties Trust CEO'su Ed Aldag, Aug2003 tarihinde atandı, in görev süresi 21.25 yıldır. in toplam yıllık tazminatı $ 17.85M olup, şirket hissesi ve opsiyonları dahil olmak üzere 5.6% maaş ve 94.4% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.8% ine doğrudan sahiptir ve bu hisseler $ 20.37M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 7.8 yıl ve 8.3 yıldır.

Anahtar bilgiler

Ed Aldag

İcra Kurulu Başkanı

US$17.9m

Toplam tazminat

CEO maaş yüzdesi	5.6%
CEO görev süresi	21.3yrs
CEO sahipliği	0.8%
Yönetim ortalama görev süresi	7.8yrs
Yönetim Kurulu ortalama görev süresi	8.3yrs

Son yönetim güncellemeleri

Recent updates

Medical Properties Trust: Investors Should Be Worried About Liquidity Issues Ahead

Nov 14

Medical Properties Trust: Buy The Dip At A 50% Discount To Book Value

Nov 08

Medical Properties Trust Q3 Preview: Rare Insider Buy Indicates Improving Sentiment

Oct 29

Medical Properties Trust: Weak Fundamentals And Bearish Technicals Vs. Low Valuations

Aug 27

Medical Properties Trust: Cash Flow Concerns Persist

Aug 21

Medical Properties Trust Is A Steal At This Price (Upgrade)

Aug 14

Medical Properties Trust: Results Incoming

Aug 06

Medical Properties Trust: The Endgame Unfolds

Jul 19

Medical Properties Trust: Why I Think It Is Worth Having A Pop

Jul 03

Medical Properties Trust: The Market Paints A Bright Future - Ignore

Jun 26

Medical Properties Trust's Turnaround Is Here - Initiate Cautious Buy

Jun 16

Medical Properties Trust: Steward Bankruptcy Exposes Shorts To Squeeze, 11.2% Dividend Yield

Jun 10

Medical Properties Trust: Renewed Risks To The Dividend

Jun 02

Medical Properties Trust Stock: Mr. Market Is Underestimating This REIT

May 25

Medical Properties: Don't Worry About The Steward Bankruptcy

May 12

Medical Properties Trust: Don't Celebrate Too Early

May 05

Very Good News For Medical Properties Trust

Apr 25

Medical Properties Trust: A Key Level Is Now In Sight (Technical Analysis)

Apr 18

Medical Properties Trust: No High Rewards Without High Risks (Rating Upgrade)

Apr 11

Medical Properties Trust Q4: Wouldn't Touch This REIT With A 10-Foot Pole

Apr 04

Medical Properties Trust: Stock Price Is Not Going Anywhere

Mar 18

Medical Properties Trust: Downgrading On Another Red Flag

Mar 07

Medical Properties Trust: Don't Fall For This Bear Market Rally

Mar 01

Medical Properties Trust Q4: No Guidance Causes Uncertainties

Feb 21

Confessions Of A Medical Properties Trust Bagholder

Jan 29

Lessons From Medical Properties Trust Stock's Implosion

Jan 16

Medical Properties Trust: A Cautionary Tale On Reaching For Yield

Jan 08

Medical Properties Trust: My Biggest Loser In 2023 (Rating Downgrade)

Jan 02

Medical Properties Trust: Dead Money At Best, Better To Avoid

Dec 25

Medical Properties Trust: Holding Through Recovery Efforts

Dec 18

Medical Properties Trust: Pricey Valuation With Various Downside Risks

Dec 04

Sell Medical Properties Trust And Buy These 10%-Yielding Blue Chips Instead

Nov 22

Medical Properties Trust: Invest In 12% Yielding Debt Over Shares

Nov 13

Medical Properties Trust: The Future Looks Bleak

Nov 02

Medical Properties Trust Is Fighting For Its Life

Oct 26

Is Medical Properties Trust A Potential Takeover Target?

Oct 20

Medical Properties Trust: Why I Am Selling At The Lows And Downgrading To 'Strong Sell'

Oct 11

Medical Properties Trust: Sifting Through The Rubble

Oct 01

Medical Properties Trust: A Disaster Investors Should Have Seen Coming

Sep 17

Medical Properties Trust: The Safest Dividend Is Probably The One That's Just Been Cut (Upgrade)

Aug 29

Medical Properties Trust: The Bottom Is In

Aug 22

Medical Properties Trust: Dividend Cut Incoming (Downgrade)

Aug 16

CEO Tazminat Analizi

Ed Aldag'un ücretlendirmesi Medical Properties Trust'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	-US$3b
Jun 30 2024	n/a	n/a	-US$2b
Mar 31 2024	n/a	n/a	-US$1b
Dec 31 2023	US$18m	US$1m	-US$558m
Sep 30 2023	n/a	n/a	-US$35m
Jun 30 2023	n/a	n/a	US$70m
Mar 31 2023	n/a	n/a	US$302m
Dec 31 2022	US$16m	US$1m	US$901m
Sep 30 2022	n/a	n/a	US$1b
Jun 30 2022	n/a	n/a	US$1b
Mar 31 2022	n/a	n/a	US$1b
Dec 31 2021	US$17m	US$1m	US$654m
Sep 30 2021	n/a	n/a	US$558m
Jun 30 2021	n/a	n/a	US$517m
Mar 31 2021	n/a	n/a	US$512m
Dec 31 2020	US$17m	US$1m	US$429m
Sep 30 2020	n/a	n/a	US$449m
Jun 30 2020	n/a	n/a	US$408m
Mar 31 2020	n/a	n/a	US$378m
Dec 31 2019	US$17m	US$1m	US$372m
Sep 30 2019	n/a	n/a	US$319m
Jun 30 2019	n/a	n/a	US$966m
Mar 31 2019	n/a	n/a	US$998m
Dec 31 2018	US$13m	US$1m	US$1b
Sep 30 2018	n/a	n/a	US$1b
Jun 30 2018	n/a	n/a	US$349m
Mar 31 2018	n/a	n/a	US$311m
Dec 31 2017	US$8m	US$950k	US$288m

Tazminat ve Piyasa: Ed 'nin toplam tazminatı ($USD 17.85M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 6.60M ).

Tazminat ve Kazançlar: Ed şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Ed Aldag (60 yo)

21.3yrs

Görev süresi

US$17,854,051

Tazminat

Mr. Edward K. Aldag, Jr., also known as Ed, is a Founder of Medical Properties Trust, Inc. and has been its President and Chief Executive Officer since August 2003. He is President, Chief Executive Officer...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Edward Aldag	Founder	21.3yrs	US$17.85m	0.80% $ 20.4m
R. Hamner	Founder	21.2yrs	US$9.11m	0.45% $ 11.4m
Rosa Hooper	Senior VP of Operations & Secretary	no data	US$2.60m	0.060% $ 1.5m
James Hanna	Senior VP	8.8yrs	US$3.04m	0.063% $ 1.6m
Larry Portal	Senior VP & Senior Advisor to the CEO	1.7yrs	US$3.49m	0.069% $ 1.8m
Tim Berryman	Managing Director of Investor Relations	no data	Veri yok	Veri yok
Andrew Babin	Senior Managing Director of Corporate Communications	4.4yrs	Veri yok	Veri yok
R. Savage	VP & Head of Global Acquisitions	no data	Veri yok	Veri yok
Charles Lambert	VP, Treasurer & MD of Capital Markets	6.8yrs	Veri yok	0.044% $ 1.1m

7.8yrs

Ortalama Görev Süresi

57.5yo

Ortalama Yaş

Deneyimli Yönetim: MPW 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.8 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Edward Aldag	Founder	20.7yrs	US$17.85m	0.80% $ 20.4m
R. Hamner	Founder	19.8yrs	US$9.11m	0.45% $ 11.4m
C. Thompson	Independent Director	8.3yrs	US$268.16k	0.0091% $ 231.7k
G. Dawson	Independent Director	20.6yrs	US$273.16k	0.026% $ 650.9k
Michael Stewart	Independent Lead Director	8.3yrs	US$288.16k	0.037% $ 938.1k
D. Sparks	Independent Director	10.2yrs	US$238.16k	0.016% $ 408.6k
Elizabeth Pitman	Independent Director	6.8yrs	US$298.16k	0.013% $ 325.3k
Emily Murphy	Independent Director	2.8yrs	US$238.16k	0.0086% $ 219.2k
Caterina Mozingo	Independent Director	4.8yrs	US$268.16k	0.0094% $ 238.8k

8.3yrs

Ortalama Görev Süresi

61yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: MPW 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 8.3 yıldır).

Medical Properties Trust Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Medical Properties Trust, Inc., Annual General Meeting, May 30, 2024

Recent updates

Medical Properties Trust, Inc. Declares Regular Quarterly Cash Dividend on Common Stock, Payable on January 9, 2025

Medical Properties Trust: Investors Should Be Worried About Liquidity Issues Ahead

Medical Properties Trust: Buy The Dip At A 50% Discount To Book Value

Medical Properties Trust, Inc. to Report Q3, 2024 Results on Nov 07, 2024

Medical Properties Trust Q3 Preview: Rare Insider Buy Indicates Improving Sentiment

Medical Properties Trust: Why Basket Making Is Important

My Biggest Loser List (Part 1): Medical Properties Trust (Rating Downgrade)

Medical Properties Trust Bulls Vs. 40%+ Short Interests

Medical Properties Trust: The Path To Gains Is Clearer Than Ever

Medical Properties Trust Soars On Positive Steward News

Upgrading Medical Properties Trust On Possible Bullish Catalyst

Medical Properties Trust: Weak Fundamentals And Bearish Technicals Vs. Low Valuations

Medical Properties Trust, Inc. Declares Regular Quarterly Cash Dividend on Common Stock, Payable on October 10, 2024

Medical Properties Trust: Cash Flow Concerns Persist

Medical Properties Trust Is A Steal At This Price (Upgrade)

Medical Properties Trust: Results Incoming

Medical Properties Trust, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Medical Properties Trust: The Endgame Unfolds

Medical Properties Trust: Why I Think It Is Worth Having A Pop

Medical Properties Trust: The Market Paints A Bright Future - Ignore

Medical Properties Trust's Turnaround Is Here - Initiate Cautious Buy

Medical Properties Trust: Steward Bankruptcy Exposes Shorts To Squeeze, 11.2% Dividend Yield

Medical Properties Trust: Renewed Risks To The Dividend

Medical Properties Trust, Inc. Declares Regular Quarterly Cash Dividend, Payable on July 9, 2024

Medical Properties Trust Stock: Mr. Market Is Underestimating This REIT

Medical Properties Trust Comments on Delayed Form 10-Q Filing and Related Notice from NYSE

Medical Properties Trust, Inc. announced delayed 10-Q filing

Medical Properties: Don't Worry About The Steward Bankruptcy

First quarter 2024 earnings released: US$1.23 loss per share (vs US$0.054 profit in 1Q 2023)

Medical Properties Trust: Don't Celebrate Too Early

Medical Properties Trust, Inc. to Report Q1, 2024 Results on May 09, 2024

Very Good News For Medical Properties Trust

Medical Properties Trust: A Key Level Is Now In Sight (Technical Analysis)

Price target increased by 7.3% to US$4.96

Medical Properties Trust, Inc. Declares Regular Quarterly Dividend, Payable on May 1, 2024

Medical Properties Trust: No High Rewards Without High Risks (Rating Upgrade)

Prime Healthcare Services, Inc. acquired Five Medical facilities in California and New Jersey from Medical Properties Trust, Inc. (NYSE:MPW) for $350 million.

Medical Properties Trust Q4: Wouldn't Touch This REIT With A 10-Foot Pole

Medical Properties Trust: Stock Price Is Not Going Anywhere

Medical Properties Trust: Downgrading On Another Red Flag

Medical Properties Trust: Don't Fall For This Bear Market Rally

Price target decreased by 8.2% to US$4.41

Full year 2023 earnings: EPS and revenues miss analyst expectations

Medical Properties Trust, Inc., Annual General Meeting, May 30, 2024

Medical Properties Trust Q4: No Guidance Causes Uncertainties

Medical Properties Trust, Inc. to Report Q4, 2023 Results on Feb 21, 2024

Price target decreased by 14% to US$4.80

Price target decreased by 7.5% to US$5.36

Confessions Of A Medical Properties Trust Bagholder

Lessons From Medical Properties Trust Stock's Implosion

Medical Properties Trust: A Cautionary Tale On Reaching For Yield

Price target decreased by 16% to US$5.85

Price target decreased by 8.5% to US$6.82

Medical Properties Trust: My Biggest Loser In 2023 (Rating Downgrade)

Medical Properties Trust: Dead Money At Best, Better To Avoid

Medical Properties Trust: Holding Through Recovery Efforts

Medical Properties Trust: Pricey Valuation With Various Downside Risks

Price target decreased by 7.2% to US$7.00

Upcoming dividend of US$0.15 per share at 13% yield

Sell Medical Properties Trust And Buy These 10%-Yielding Blue Chips Instead

Medical Properties Trust: Invest In 12% Yielding Debt Over Shares

Levi & Korsinsky, LLP Notifies Medical Properties Trust, Inc. Investors of A Class Action Lawsuit

Medical Properties Trust, Inc. Declares Regular Quarterly Dividend, Payable on January 11, 2024

New minor risk - Share price stability

Medical Properties Trust: The Future Looks Bleak

Price target decreased by 7.6% to US$8.50

Medical Properties Trust, Inc. Investors Have Opportunity to Lead Medical Properties Trust, Inc. Securities Fraud Lawsuit

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Medical Properties Trust, Inc. Reports Unaudited Impairment Charges Results for the Third Quarter Ended September 30, 2023

Medical Properties Trust, Inc. Provides Unaudited Earnings Guidance for the Year 2023

Medical Properties Trust Is Fighting For Its Life

Is Medical Properties Trust A Potential Takeover Target?

Medical Properties Trust, Inc. to Report Q3, 2023 Results on Oct 26, 2023

Price target decreased by 7.8% to US$8.55